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Abnormal Chromosome Repair and Risk of
Developing Cancer
by William W. Au1
Several scientists have proposed that DNArepairdeficiencies and the induction ofa mutator phenotype are
responsible for the generation of multiple mutagenic alterations in cancer cells. I propose that exposure to
environmental carcinogens can induce DNA lesions, elicit infidelity ofDNA repair, and cause the instability
phenomenon and the subsequent consequences. Using cell lines derived from mammary glands ofirradiated
mice, my laboratory conducted sequential studies to document genetic events leading to the development of
malignant cells in vitro. We found that aneuploidy and extensive chromosome breaks and rearrangements
occurred early. This is followedby inactivation ofthe retinoblastomatumor-suppressorgene, amplification of
themyconcogene,andexpressionofthetumorigenicphenotype. Ourobservationofchromosome instabilityat
the early phase oftransformation is consistent with the mutator phenotype. We suggest that a cause ofthe
instability is infidelity ofDNArepair, and we have developed achallenge assay to elucidate this phenomenon.
Inthis assay, cells are challenged to repairradiation-induced DNA lesions. In one ofourstudies,lymphocytes
from cigarette smokers and nonsmokers were exposed to y raysin vitro. Cells from smokers had significantly
more rearranged chromosomes than cells from nonsmokers after the challenge. These data suggest that
smokershaveinfidelityofDNArepairandthatthisrepairproblemisacauseofhealtheffectsinsmokers. Inan
in vitro study, lymphocytes were exposed to mitomycin C orto nickel acetate and then irradiated with y rays.
Significantly increasedfrequencies ofrearranged chromosomes were detectedwithlow doses ofmitomycinC
and nickel, which do not cause chromosome damage by themselves. Lymphocytes from patients with
epidermodysplasiaverruciformis werefoundtohave infidelityofDNArepairafterexposuretoUV-lightin our
challengeassay.Thissensitivityisconsistentwiththepredispositiontoskincancerafterexposuretosunlight.
Ourstudiessuggestthatinfidelityofchromosome/DNArepaircangenerate anunstablegenome,whichallows
genetic alterations relevant to the development of cancer to evolve. Furthermore, infi'delity ofchromosome/
DNA repair allows the generation ofmultiple genetic alterations in the multistep carcinogenic process.
Introduction
Itiswell documented that the majority of cancers from
human have chromosome abnormalities (1,2). Further-
more, single and specific chromosome abnormalities are
consistently associatedwith certain cancers. Forexample,
Burkitt's lymphomasusuallyhave atranslocationbetween
chromosomes 8 and 14. Retinoblastomas often have a
deleted chromosome 13. These nonrandom cytogenetic
changes clearlyindicate that alteration ofspecific genes is
the cause of certain cancers. Indeed, extensive searches
using molecular techniques have concluded that develop-
ment of Burkitt's lymphoma and retinoblastoma involves
amplication ofthe myc oncogene andinactivation oftheRb
tumor-suppressor gene,respectively(3,4). Thecytogenetic
abnormalities observed in most other cancers, however,
involve more than one chromosome. Therefore, alteration
ofseveral genes maybe required for development ofthese
cancers.
The relationship between these chromosome changes
and alteration of oncogenes in human cancers are summa-
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rizedbyYunisandSoreng(5)and LeBeau(6). Itisobvious
that carcinogenesis is a complex, multistep process (7). In
most cases, a sequence of specific genetic alterations is
required to convert a normal cell through a multistep
process and clonal expansion to become a cancer cell. It is
therefore necessary to have a good understanding ofthe
carcinogenic process to precisely estimate the risk for
developingcancer. Inthispaper, somefactorsthatcontrib-
ute to the development ofcancer are briefly summarized.
In addition, the use of our challenge assay to detect
infidelity of DNA repair and as a biomarker for risk of
developing cancer is presented.
Genetic Factors for Developing
Cancer
Multicellular organisms have a host ofgenes that regu-
late cell growth and cell-cell interactions. Alteration of
these genes may lead to abnormal cell differentiation and
proliferation. Inheritance of these abnormal genes may,
therefore, predispose an individual to an increased risk of
developing cancer.
One ofthese genes is the retinoblastoma (Rb) gene. In
1971, Knudson predicted, based on statistical analyses,
that twomutational events were sufficientforthe develop-W W AU
mentofretinoblastoma (8). Patientswithpredisposition to
develop this tumor would have inherited one of the two
mutational events,therefore, theywoulddevelopthetumor
early in life and would have multiple tumors. The primary
mutational event was documented cytogenetically by
Yunis and Ramsay (9) to be a specific deletion in chromo-
some 13. Using molecular techniques, Friend et al. (10),
Leeetal.(11), andFungetal. (12)simultaneouslyidentified
the DNA sequence that is deleted in Rb patients. This
sequence and its corresponding gene is known as the Rb
gene. The primary function ofthis gene is to control cell
proliferation (13). The two mutational events as predicted
by Knudson are shown to be homozygous deletion of the
Rb gene. Becauseinactivation ofthis geneis necessaryfor
the development of cancer, this and other genes with
similar involvement in carcinogenesis are classified as
tumor-suppressor genes (14,15).
Inheritance of one defective tumor-suppressor gene
would increase the chance of homozygous inactivation of
the gene and would therefore significantly increase the
risk ofdeveloping retinoblastoma. On the other hand, two
sequential de novo mutations that inactivate a tumor-
suppressor gene (e.g., homozygous deletion) can also
occur, albeitwith muchreduced frequency. This is, infact,
observed inRb patients who have not inherited the defec-
tive Rb gene from their parents. Because the probability
for two sequential hits to inactivate a gene is low, these
patients usually have retinoblastoma later in life than
those who have already inherited one defective Rb gene.
Damage is frequently induced in DNA on a dailybasis,
but cells have excellent DNA repair enzymes that correct
the damage and restore normal cellular functions. Inheri-
tanceofgenesthatcodefordefective DNArepairenzymes
would cause mistakes duringthe DNArepairprocess and
would predispose the individuals to develop cancer. For
example, patients with xeroderma pigmentosum are
unable torepairUY-induced damage in cellular DNA, and
they have a high incidence of skin cancer (16). Other less
well-characterized patients are those with Bloom syn-
drome, Fanconi anemia, and ataxia telangiectasia. These
diseases are recessively inherited syndromes with a pre-
disposition to develop cancer. Although the homozygotes
for these diseases can be easily identified, the hetero-
zygotes are phenotypically normal and are indistinguish-
able from normal individuals. However, Swift etal. (17-19)
have demonstrated that these heterozygotes also have
increased risk to develop cancer compared to the general
population. Therefore, these defective genes can also be
genetic risk factors in the heterozygous state. The extent
oftheircontribution to cancerincidence amongthepheno-
typically normal population remains to be determined.
Our environment contains natural and man-made haz-
ardous agents, and exposure to them may cause cancer.
Complex organisms have developed defense mechanisms
against the assault by xenobiotics. One of the defense
mechanisms is the use ofmetabolizing enzymes to break
down reactive chemicals and consequently inactivate
them. Unfortunately, some chemicals are activated in this
metabolizing process. An example is the metabolic activa-
tion of polycyclic aromatic hydrocarbons by cytochrome
P-450 enzymes (20) into chemicals that can interact with
DNA. These enzymes are inducible, and their inducibility
varies from one individual to the next. It is therefore
believed that individuals with high inducibility of these
enzymeswouldhaveincreasedriskto develop cancerfrom
exposure to polycyclic aromatic hydrocarbons and other
chemicals thatrequire similar enzyme systems for activa-
tion. Indeed, this relationship was demonstrated recently
by Bartsch et al. (21), who reported that the inducible
phenotype is associated with risk ofdeveloping lung can-
cer amongcigarette smokers. Thesegeneticallyregulated
metabolic activities are therefore risk factors for develop-
ing cancer from exposure to environmental carcinogens.
Environmental Factors for Developing
Cancer
Physical, chemical, and biological agents that can cause
cancer are present in our environment. Some of these
agents existnaturally, and others are produced byhuman
activities. Ionizing radiation is one of the earliest docu-
mented human carcinogens. Among biological agents,
viruses such as papillomavirus and hepatitis B virus are
believed to be responsible for a significant portion of
cancerincidence worldwide (22). On the otherhand, in de-
veloped andinmanydevelopingcountries, cigarette smok-
ingisgenerallyrecognizedtobethemostsignificantcause
of cancer in human. In addition to smokers, nonsmokers
who are exposed to sidestream smoke from burning ciga-
rettes may also have an increased risk of developing
cancer (23).
Humancarcinogens are alsopresentinworkplaces. The
International Agency for Research on Cancer (24) has
documented these carcinogens. Scientists are actively
seeking out environmental factors that can cause cancer
because removal of the identified factors are effective
preventive measures against cancer development.
Inourlaboratory,wehaveconductedavarietyofstudies
to identify some of the environmental risk factors. In
several recent studies, we investigated the interactions
between different environmental chemicals for induction
ofchromosome aberrations in vivo. We concentrated our
effortontheinteractionbetweenaubiquitousenvironmen-
tal carcinogen, benzene, and commonly used drugs and
pharmaceutical chemicals (25). We reported that awidely
usedantischistosomal drug,praziquantel, canenhancethe
metabolism ofbenzene to form active metabolites and can
enhance theinduction ofmicronuclei inbone marrowcells
of mice (26). A commonly used emulsifier in the phar-
maceutical, cosmetic, and animal-raising industries, cre-
mophore, can also enhance the clastogenic effect of
benzene (27). We found that the enhancement effect of
cremophore is correlated with a significant induction of
cytochrome P-450I family of enzymes and the increased
presence ofactivated benzene metabolites in vivo. On the
other hand, co-administration of benzene with dimethyl-
sulfoxide reduced the metabolism of benzene and its
clastogenic activities (28). Because dimethylsulfoxide is a
good free-radical scavenger, the latter observation indi-
cates thatmetabolic activation ofbenzene mayrequirethe
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formation offree radicals. Our studies and those ofothers
clearlyindicate the significant and complexcontribution of
environmental carcinogens in causation of cancer in
humans.
Multiple Causes and Multiple
Processes in Carcinogenesis
It is well known that not everyone who is exposed to
similar concentrations of the same carcinogen will ulti-
mately develop cancer. In fact, data from various epi-
demiological studies suggestthatapproximately 1 outof10
heavycigarette smokerseventuallydevelopedlung cancer.
There is no doubt that some ofthe risk factors mentioned
earlier contribute to cancer outcome. The fact that histo-
logically identical cancer can be caused by different
etiological agents and that cancer develops through a
multistage process allows the documented risk factors to
influence the outcome at different stages and, perhaps,
with different mechanisms. Therefore, it is difficult to
estimate cancer risk quantitatively even though the risk
factors are identified. On the other hand, by documenting
thebiologicaVgenetic events that are essential forcarcino-
genic process, it is possible to estimate cancer risk based
on biomarker analysis. This approach is believed to be
more precise than the estimate based on risk factors.
One of the well-documented genetic events in develop-
ment of cancer in humans was discovered by Vogelstein
and his colleagues (29). They found that alteration of
several genes are required for the development ofcolorec-
tal cancer.Atypical sequence ofeventsinvolves the altera-
tion of chromosome 5 followed by mutagenic activation of
Ki-ras oncogene and alteration ofchromosomes 18 and 17.
Although the mechanisms involved in these specific
genetic alterations are not yet elucidated, it has been
hypothesized that certain genes maycontain mutation hot
spots sothatthey canbemutatedreadilyafter exposureto
carcinogenic agents. The observed involvement of the
mutated p53 tumor-suppressor gene with different muta-
tion spectra in different types of human cancer (30) is
consistent with this hypothesis. On the other hand, it is
difficult to provide an explanation for the mechanisms for
multiple genetic alterations in the multistep carcinogenic
process. Experimentally, it has been adequately demon-
strated that an acute exposure to acarcinogen is sufficient
to produce cancer in animals several months later. Based
on this and other evidence, Loeb proposed that "an early
step in tumor progression is one that induces a mutator
phenotype" (31). Hearguedthatthe spontaneous mutation
rate in somatic cells is not sufficient for the induction of
multiple mutations in many cancers, but the induction of a
mutator phenotype could increase the mutation rate and
accountforthephenomenon. Itisreasonabletoacceptthat
themutatorphenotype is ageneral riskfactorfordevelop-
ment of cancer. A cell's inability to correctly repair DNA
damage is one ofthe mechanisms that generate the muta-
tor phenotype. In our laboratory, we have developed a
challenge assay to detect the infidelity of DNA repair
phenomenon. The details ofthis approach arepresentedin
a later section ofthis paper.
Genetic Alterations in Mouse
Mammary Tumors
Use ofhuman tissues to documentgenetic eventsin car-
cinogenesis is limited by the availability of materials. In
most cases, specimens can be obtained only from tumors
that are at the end of the carcinogenic process. For this
reason, many scientists turn to using experimental tumor
modelstodocumentchangesduringtheentire process.We
have used an in vivo-in vitro mouse mammary tumor
model for our study.
Our model for the studyis based on the work ofUllrich
and his colleagues (32,33). In thismodel, femalemice were
irradiated with a carcinogenic dose of 1 Gy of y rays. At
different times after the irradiation, but long before the
development of mammary tumors, cells from the mam-
mary glands were used to establish cell lines. The cells
were characterized for their abilityto populate mammary
glands and fortheirtumorigenic phenotype. Manycell lines
atvarious stages in the transformation process were estab-
lished and stored in liquid nitrogen. Two lines (lLAl and
137V8C15) developed from nontumorigenic to tumorigenic
phenotypes within approximately 25 in vitro passages.
ThecelllinellAl wasderivedfrom a mammaryglandof
an irradiated mouse 4 weeks after the irradiation. After
the cells became established in culture, they wereinjected
into the fat pad region of mammary glands in virgin (21
days old) female mice to test for their ability to produce
normal ductal outgrowth in vivo. The cells' ability to
produce ductal growthindicates thatthey were mammary
cells. Cells with diploid DNA content were selected for
further propagation in vitro and subcloned cell lines were
derived from them. Cell line llAl is one of the subelones.
We studied these cells using cytogenetic and molecular
techniques to document changes that are related to the
malignant transformation process.
A summary of our observations from analysis of the
llAl celllineis showninTable1.At passage 6, cytogenetic
analyses showed that these cells had a near tetraploid
modal chromosome number. In addition, high frequencies
of chromosome breakage and rearrangement were
observed. At later passages, the chromosome numbers
were reduced to near diploid. At passage 42, the chromo-
some number is 40; however, several rearranged chromo-
somes were detectedbychromosome bandingprocedures.
One large metacentric marker chromosome was formed.
Table 1. Genetic alterations in irradiated mouse mammary cells
during the transformation process.a
In vitro passage numberb
Observed changes 6 11 24 42
Model chromosome number 78 74 41 40
% Metacentric translocation 50 37 90 100
Rb gene inactivation - + + + + +
mycAmplification - - + + +
Tumorigenesis - - + +
aCell line1lAI was established frommammaryglands ofmice 4weeks
after 1 Gy of y-irradiation.
b(_) Negative response; (+) positive response; (+ +) more intense
positive response.
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The same passages of cells were evaluated using
molecular techniques. Isolated DNA from various pas-
sages ofcells were cutbyMspI restriction enzyme, sepa-
rated by agarose gel electrophoresis, and hybridized with
32P-labeled Rbprobes. Thebandingpatterns ofthe South-
ern blot analyses showthattheRb gene is mutated in the
early passages, from passage 11 to 42 [Table 1 (34,35)].
Thisledtoinactivation ofthegene.Thelatterisconfirmed
by Northern blot analysis for the lack of Rb messenger
RNAandbyimmunofluorescentanalysisforthelackofRb
protein (data not presented). Southern blot analyses for
alterations ofseveral oncogenes showthat onlythe c-myc
oncogene is amplified (lable 1). The amplification is corre-
lated with the presence ofdouble minute chromosomes in
the same passage of cells. The amplication of the c-myc
oncogene occurred in cells at a later passage than the
inactivation oftheRb gene but atthe same timewhen the
cells became tumorigenic upon injection into host mice.
Ourdataindicatethatthe sequence ofgenetic eventsfor
mouse mammary cells to acquire tumorigenic potential is
genetic instability, inactivation of the Rb tumor-suppres-
sor gene, and amplification of the c-myc oncogene. Our
observation provides further evidence forthe involvement
of several cellular genes in the carcinogenic process. Our
observed genetic instability is consistent with the "muta-
torphenotype" as a crucial event in the process. Itis very
likelythatthe observed sequence ofalterations isinitiated
byexposure ofmammarycells to y rays invivo before cell
lines were established. Affected cells have gene mutations
and/or chromosome abnormalities, which interfere with
normal cellular functions. One ofthem may be fidelity of
DNArepair.Wehavedevelopedachallengeassaytodetect
infidelity of DNA repair.
Cytogenetic Detection of Infidelity of
DNA Repair
ItiswellacceptedthatinabilitytorepairdamagedDNA
is afundamental mechanism to produce cancer. This phe-
nomenon is well documented in patients who have DNA
repair deficiencies and are predisposed to develop cancer
(e.g., patients with xeroderma pigmentosum and Bloom
syndromes). Because cells have different efficiencies for
repair of damage in different genes (36), general DNA
repairdeficiencies mayproducemutationinspecific genes.
Therefore,infidelityofDNArepairmaybe acrucialmech-
anisminthegeneration ofmultiple, specific genetic altera-
tions in the multistep carcinogenic process. However, a
simple and efficient assay to detect infidelity of DNA
repair is not available. We have developed a challenge
assaybyusingcytogenetictechniques toaddresstheDNA
repair problems.
We hypothesize that physical and chemical agents that
can react with DNA and proteins (e.g., DNA repair
enzymes) can, even atverylowdoses, interferewith DNA
repair processes. If these cells are subsequently chal-
lenged by exposing them to a defined dose of y rays that
can induce a finite amount of DNA lesions, the cells will
have problems repairing the radiation-induced damage
correctly. DNA fragments may not rejoin to the original
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FIGURE 1. Hypothesized processes for infidelity of chromosome/DNA
repairafterexposureto carcinogens. The formation ofrearranged DNA
molecules that can be identified as dicentric chromosomes and acentric
fragments is shown.
molecules. These abnormally repaired products can be
detected as chromosome-type aberrations. Because
chromosome-type abnormalities (e.g. dicentric chromo-
somes) are formed soon afterirradiation and before DNA
replication (37), we assume that the observed chromo-
some-type aberrations indicate infidelity of DNA repair.
The basis for our hypothesis is diagrammatically illus-
trated in Figure 1. Furthermore, as described earlier,
many cancer predisposition syndromes are due to DNA
repair deficiencies. Therefore, cells from these patients
will have increased chromosome rearrangements after
theircells areexposedtoagentssuchasionizingradiation.
In one ofourrecent studies, lymphocytesfrom age- and
sex-matched cigarette smokers and nonsmokers were
investigated using our challenge assay (38). Several irra-
diation conditions were used. In one condition, cells were
irradiated with a single dose of100 cGy ofX-rays during
the Go phase ofthe cell cycle. Other cells were irradiated
with two doses of100 cGyeach separated by15 or 60 min.
Unirradiated cells served as controls. We found that the
chromosome translocation frequencies were consistently
higher in smokers compared to nonsmokers under all
three irradiation conditions (p < 0.38; p < 0.10; p < 0.05,
respectively). Our dataindicate that exposure to cigarette
smoke caninduceinfidelity ofDNArepair, and this abnor-
mality may be one of the mechanisms for induction of
serious health problems among smokers.
Mitomycin C (MMC) is known to form crosslinks with
DNA and proteins, and we have used this chemical as a
positive control to test our challenge assay. Lymphocytes
from normal volunteers were exposed to 0, 0.01, and 0.1
pLg/mL ofMMC. One hourlater, cells werewashed free of
the chemical and irradiated 30 min later with y rays. As
shown in Figure 2, MMC caused significant enhancement
of radiation-induced chromosome rearrangements. The
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FIGURE 2. Induction ofinfidelity ofDNArepair in human lymphocytes after exposure to mitomycin C (MMC). Cellswere exposed to 0, 0.01, or 0.1 jig/
mL for 1 hr, washed, and irradiated 1 hr later with one dose of100 cGy or two doses of100 cGy (each separated by 15 min) of y rays.
enhancement is detected with exposure to low doses of
MMC, even when MMC does not induce chromosome
aberrations by itself (0.01 [g/mL). Our data indicate, as
expected, that crosslinks from exposure to MMC can
cause infidelity of DNA repair.
Ithas been known for some time that some carcinogens
are not genotoxic as defined by standard genotoxicity
assays. Such carcinogens are generally known as non-
genotoxic carcinogens (39). One nongenotoxic carcinogen
is nickel. We have conducted a studywith nickel acetate to
determine whether this chemical can induce infidelity of
DNA repair (40,41). Lymphocytes were exposed to 0.1-
1000 FLM nickel acetate for 1 hr, washed, and then irradi-
ated 30 min later with two 75 cGy y rays separated by 60
min. Theresultissummarizedin Figure 3. Figure 3 shows
a significant dose-dependent enhancement of radiation-
induced chromosome rearrangements (analysis of vari-
ance: p < 0.02). A reduction ofthe enhancement effect at
the high dose is probably due to toxicity of nickel to cells
and/or to the repair processes.
Lymphocytes from patients who are predisposed to
develop cancer are also used to investigate their efficien-
cies for DNA repair. These patients have Basal Cell
Naevus Syndrome or epidermodysplasia verruciformis
(EV). In addition to using y rays, UV light was used as a
challenging agent. Cells from both types ofpatients were
exposedto yraysinourchallenge assay,butonlycellsfrom
EV patients were exposed to UV light. Our data indicate
that cells from both types ofpatients were not excessively
deficientinrepairing yray-induced DNAdamage,whereas
EV cells enhanced the UY-light-induced chromosome
abnormalities by 4-fold over response from normal indi-
viduals (42). The extreme sensitivity of EV cells to UV
light is consistent with their predisposition to UV-light
induced skin cancer.
ANOVA test; p<0.02
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FIGURE 3. Induction ofinfidelity of DNA repair in human lymphocytes
after exposure to nickel acetate. Cells were exposed to 0-100 p.M nickel
acetate for 1 hr, washed, and irradiated 1.5 hr later with two doses of75
cGy (separated by 60 min) ofy rays.
Conclusion
Evidencewaspresented to emphasize the need to docu-
ment factors that contribute to the development ofcancer.
Although it is possible to prioritize cancer risk using this
and other data, additional information is needed for quan-
titative risk evaluation. Information is needed on the iden-
tification ofbiomarkersthatpredictcarcinogenic outcome.
Information is also needed on DNA repair problems and
altered expression ofcancer-related genes such as tumor-
suppressor genes and oncogenes.
Thedevelopmentofachallengeassaytodetectinfidelity
of DNA repair was presented, and some substantiative
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data were provided. It can be envisioned that infidelity of
DNA repair can generate multiple genetic changes and
therefore provide an opportunity for the alterations that
are relevant to the development of cancer to evolve.
Infidelity of DNA repair is potentially a mutator pheno-
type that is responsible for the generation of multiple
genetic alterations in the multistep carcinogenic process.
This and other relevant biomarkers may be useful for
estimating cancer risk with additional precision.
Preparation of this manuscript was partially supported by a grant
from the US Department of Health and Human Services (ROl ES
0492601A2), The Texas Legisiature, and a contract from the Texas
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